Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2020-11-23 Capital/Financing Update
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
Other.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'Warrant Indenture Providing for the Issue of Warrants' and is a legal agreement dated November 20, 2020, between PharmaCielo Ltd. and Computershare Trust Company of Canada as the Warrant Agent. It contains detailed articles and sections about the interpretation, issuance, exercise, adjustment, rights, enforcement, meetings, and other provisions related to warrants. This is a formal legal contract governing the terms and conditions of warrants issued by the company, which is a capital/financing instrument. It is not a report, announcement, or regulatory filing but a contractual document related to capital structure and financing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full indenture, not a brief announcement or summary.
2020-11-23 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of a $10 million private placement by PharmaCielo Ltd. It details the terms of the offering, use of proceeds, related party transactions, and amendments to stock option plans. There is no presentation of financial statements or detailed financial performance data. The document focuses on financing activities and capital raising, including issuance of units, warrants, and related fees. It is not an annual or interim report, earnings release, or management discussion. The content fits the definition of a Capital/Financing Update, as it provides an update on company fundraising and capital structure changes.
2020-11-23 English
News release - English.pdf
Regulatory Filings
2020-11-19 English
News release - English.pdf
Regulatory Filings
2020-11-18 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a conference call to discuss PharmaCielo's third quarter 2020 financial results. It provides details about the call date, time, and access information but does not contain the actual financial results or substantive financial data. The document length is 2774 characters, which is relatively short and consistent with an announcement rather than a full report. According to the classification rules, announcements of conference calls or earnings discussions without the actual transcript or financial data should be classified as Call Transcript (CT) only if the full transcript is provided. Since this is only an announcement of the call, it does not qualify as a Call Transcript. It is also not a report publication announcement (RPA) because it does not mention a report being attached or published. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the upcoming earnings call.
2020-11-16 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing PharmaCielo's participation in the 2020 Cowen Boston Cannabis Conference. It contains no financial data, no report or filing, no voting results, no management changes, no earnings information, and no regulatory certifications. It is a general corporate announcement about an upcoming investor event. The document length is short (2520 characters) and it does not mention any report being attached or published. Therefore, it does not fit into any specific financial report category. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other categories.
2020-11-13 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.